STAAR Surgical Co financials

  1. Home
  2. Financials
  3. STAA
STAA CIK 0000718937

Source: EDGAR filings · Built 2026-06-02T04:06:30Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow -40.09M -7.83M -3.75M 17.48M 29.97M 11.99M
EBITDA -83.39M -5.72M 33.22M 48.31M 36.98M 9.86M
Working Capital 243.04M 297.63M 300.23M 260.01M 222.61M 175.18M
Net Debt -114.80M -105.42M -147.20M -55.44M -167.65M -143.03M
Gross Margin 76.19% 76.32% 78.36% 93.29% 77.51% 536.72%
Operating Margin -38.30% -4.02% 8.71% 18.29% 14.47% 30.69%
Net Margin -33.60% -6.44% 6.62% 16.57% 11.94% 26.81%
Return on Equity (ROE) -23.37% -5.09% 5.53% 11.80% 10.52% 3.00%
Return on Assets (ROA) -17.81% -3.97% 4.37% 9.47% 7.96% 2.30%
Current Ratio 4.55× 5.23× 5.62× 6.03× 5.56× 5.25×
Debt-to-Equity 0.11× 0.10× 0.09× 0.09× 0.12× 0.05×
Effective Tax Rate 2.21% -123.24% 36.65% 12.92% 12.12% 28.47%
Cash Conversion Ratio 0.43× -0.78× 0.68× 0.90× 1.60× 3.54×
Accruals Ratio -0.10× -0.07× 0.01× 0.01× -0.05× -0.06×
SBC % of Revenue 12.77% 8.67% 7.29% 8.51% 6.34% 55.08%
CapEx Coverage -5.84× 0.67× 0.80× 1.96× 3.14× 2.34×
Free Cash Flow Per Share $-0.81 $-0.16 $-0.08 $0.35 $0.61 $0.25

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) — — 72.58× 60.67× 163.04× 660.17×
P/FCF — — — 137.12× 150.66× 316.88×
FCF Yield — — — 0.73% 0.66% 0.32%
EV / EBITDA — — 41.45× 47.29× 113.27× 358.86×
P/S 4.87× 3.80× 4.73× 9.77× 18.90× 167.00×
P/B 3.39× 3.00× 3.95× 6.96× 16.66× 18.67×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax — — — — — 22.05M
Revenues 239.44M 313.90M 322.42M 239.44M 230.47M 163.46M
Cost of Goods and Services Sold 57.02M 74.32M 69.76M 61.01M 51.84M 45.10M
Gross Profit 182.42M 239.58M 252.65M 223.38M 178.64M 118.36M
Research and Development Expense 40.05M 45.32M 40.48M 35.98M 33.86M 31.92M
Selling, General and Administrative Expense 274.13M 252.19M 224.55M 179.58M 145.30M 111.59M
Operating Income (Loss) -91.71M -12.61M 28.10M 43.80M 33.34M 6.77M
Income Tax Expense (Benefit) -1.81M 11.16M 12.35M 5.89M 3.79M 2.35M
Net Income (Loss) Attributable to Parent -80.45M -20.21M 21.35M 39.66M 27.51M 5.91M
Earnings Per Share, Basic $-1.62 $-0.41 $0.44 $0.83 $0.58 $0.13
Weighted Average Number of Shares Outstanding, Basic 49.57M 49.13M 48.52M 47.99M 47.21M 45.60M
Earnings Per Share, Diluted $-1.62 $-0.41 $0.43 $0.80 $0.56 $0.12
Weighted Average Number of Shares Outstanding, Diluted 49.57M 49.13M 49.43M 49.38M 49.46M 47.95M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 153.15M 144.16M 183.04M 86.48M 199.71M 152.45M
Assets, Current 311.55M 367.94M 365.27M 311.72M 271.41M 216.42M
Assets 451.68M 509.52M 488.69M 418.82M 345.78M 257.42M
Liabilities, Current 68.50M 70.31M 65.04M 51.72M 48.80M 41.24M
Liabilities 107.49M 112.19M 102.74M 82.71M 87.22M 60.19M
Stockholders' Equity Attributable to Parent 344.18M 397.33M 385.95M 336.11M 261.57M 197.22M
Common Stock, Shares, Outstanding 49.40M 49.29M 48.84M 48.21M 47.72M 46.49M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities -34.23M 15.72M 14.59M 35.72M 43.96M 20.95M
Payments to Acquire Property, Plant, and Equipment 5.82M 23.39M 18.19M 18.11M 13.64M 8.40M
Net Cash Provided by (Used in) Investing Activities 46.34M -59.22M 74.35M -156.38M -13.64M -8.40M
Payments for Repurchase of Common Stock 6.46M — — — — —
Net Cash Provided by (Used in) Financing Activities -4.55M 5.72M 7.42M 8.30M 17.79M 19.57M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (STAA CIK 0000718937), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

STLD

Steel Dynamics, Inc.

CERT

Certara, Inc.

LCUT

LIFETIME BRANDS, INC.